96. Ma, Q., et al. (2019), ‘Impact of microbiota on central nervous system and neurological diseases: the gut — brain axis’: https://jneuroinflammation.biomed.central.com/articles/10.1186/s12974-019-1434-3. 97. Bischoff, S.C., et al. (2014), ‘Intestinal permeability — a new target for disease prevention and therapy’: www.ncbi.nlm.nih.gov/pmc/articles/PMC4253991/. 98. Li, Y, et al. (2018), ‘The Role of Microbiome in Insomnia, Circadian Disturbance and Depression’, Frontiers in Psychiatry, 9(December):1–11. 99. Appleton, J. (2018), ‘The Gut — Brain Axis: Influence of Microbiota on Mood and Mental Health’: www.ncbi.nlm.nih.gov/pmc/articles/PMC6469458/. 100. D’Mello, C., et al. (2015), ‘Probiotics Improve Inflammation-Associated Sickness Behavior by Altering Communication between the Peripheral Immune System and the Brain’: www.jneurosci.org/content/35/30/10821.full. 101. Ganci, M., et al. (2019), ‘The role of the brain — gut — microbiota axis in psychology: The importance of considering gut microbiota in the development, perpetuation, and treatment of psychological disorders’: www.ncbi.nlm.nih.gov/pmc/articles/PMC6851798/. 102. Parkar, S.G., et al. (2019), ‘Potential role for the gut microbiota in modulating host circadian rhythms and metabolic health’, Microorganisms, 7(2):1–21. 103. Fasano, A. (2020), ‘All disease begins in the (leaky) gut: role of zonulin-mediated gut permeability in the pathogenesis of some chronic inflammatory diseases’: www.ncbi.nlm.nih.gov/pubmed/32051759F1000. 104. Kolacz, J. and Porges, S.W. (2018), ‘Chronic Diffuse Pain and Functional Gastrointestinal Disorders After Traumatic Stress: Pathophysiology Through a Polyvagal Perspective’: www.ncbi.nlm.nih.gov/pubmed/29904631. 105. Maes, M. and Twisk, F.N. (2009), ‘Why myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) may kill you: disorders in the inflammatory and oxidative and nitrosative stress (IO&NS) pathways may explain cardiovascular disorders in ME/CFS’: www.ncbi.nlm.nih.gov/pubmed/20038921. 106. Maes, M. (2009), ‘Inflammatory and oxidative and nitrosative stress pathways underpinning chronic fatigue, somatization and psychosomatic symptoms’: www.ncbi.nlm.nih.gov/pubmed/19127706. 107. Yu, LC-H. (2018), ‘Microbiota dysbiosis and barrier dysfunction in inflammatory bowel disease and colorectal cancers: exploring a common ground hypothesis’: www.ncbi.nlm.nih.gov/pmc/articles/PMC6234774/. 108. Bures, J., et al. (2006), ‘Small intestinal bacterial overgrowth syndrome’, World Journal of Gastroenterology, 16(24):2978–90. 109. Saffouri, G.B., etal. (2019), ‘Small intestinal microbial dysbiosis underlies symptoms associated with functional gastrointestinal disorders’: www.ncbi.nlm.nih.gov/ pmc/articles/PMC6494866/. 110. Sachdev, A.H. and Pimentel, M. (2013), ‘Gastrointestinal bacterial overgrowth: pathogenesis and clinical significance’: www.ncbi.nlm.nih.gov/pubmed/ 23997926. 111. Pimentel, M., et al. (2004), ‘A link between irritable bowel syndrome and fibromyalgia may be related to findings on lactulose breath testing’: www.ncbi.nlm.nih.gov/pubmed/15020342. Глава 10. Гормоны и резервная энергетическая система тела 112. Cadegiani, F.A. and Kater, C.E. (2016), ‘Adrenal fatigue does not exist: a systematic review’: www.ncbi.nlm.nih.gov/pmc/articles/PMC4997656/. 113. Wyller, V.B., et al. (2016), ‘Altered neuroendocrine control and association to clinical symptoms in adolescent chronic fatigue syndrome: a crosssectional study’: www.ncbi.nlm.nih.gov/pubmed/27149955. 114. Torres-Harding, S., et al. (2008), ‘The associations between basal salivary cortisol and illness symptomatology in chronic fatigue syndrome’: www.ncbi.nlm.nih.gov/pmc/articles/PMC2730359/. 115. Ludwig, D.S. (2014), ‘Clinical update: the low-glycaemic-index diet. https://www.thelancet.com/journals/lancet/article/PIIS01406736%2807%2960427-9/fulltext. 116. Savage, D.B., et al. (2007), ‘Disordered Lipid Metabolism and the Pathogenesis of Insulin Resistance’: www.ncbi.nlm.nih.gov/pmc/articles/PMC2995548/. 117. Moghaddam, E., et al. (2006), ‘The Effects of Fat and Protein on Glycemic Responses in Nondiabetic Humans Vary with Waist Circumference, Fasting Plasma Insulin, and Dietary Fiber Intake’: https://academic.oup.com/jn/article/136/10/ 2506/4746688. 118. Hucklebridge, F., et al. (2005), ‘The diurnal patterns of the adrenal steroids cortisol and dehydroepiandrosterone (DHEA) in relation to awakening’: www.sciencedirect.com/science/article/abs/pii/S030645300400071X. 119. Arendt, J. (2006), ‘Melatonin and Human Rhythms’: www.tandfonline.com/doi/full/10.1080/07420520500464361. 120. Pevet, P. and Challet, E. (2011), ‘Melatonin: Both master clock output and internal time-giver in the circadian clocks network’: www.sciencedirect.com/science/article/abs/pii/S0 928425711000040?via%3Dihub. 121. Videnovic, A., et al. (2014), ‘Circadian melatonin rhythm and excessive daytime sleepiness in Parkinson disease’: www.ncbi.nlm.nih.gov/pubmed/24566763 JAMA. 122. Tsang, A., et al. (2014), ‘Interactions between endocrine and circadian systems’: https://jme.bioscientifica.com/view/journals/jme/52/1/R1.xml. 123. Cajochen, C., et al. (2011), ‘Evening exposure to a light-emitting diodes (LED)- backlit computer screen affects circadian physiology and cognitive performance’: www.physiology.org/doi/10.1152/japplphysiol.00165.2011. 124. 124 Cajochen, C., et al. ‘High Sensitivity of Human Melatonin, Alertness, Thermoregulation, and Heart Rate to Short Wavelength Light’: https://pubmed.ncbi.nlm.nih.gov/15585546/2005. 125. Schmidt, C., et al. (2018), ‘Light exposure via a head-mounted device suppresses melatonin and improves vigilant attention without affecting cortisol and comfort’: https://orbi.uliege.be/bitstream/2268/226193/1/Schmidt 2018 PsyCh.pdf. 126. Green, A., et al. (2017), ‘Evening light exposure to computer screens disrupts human sleep, biological rhythms, and attention abilities’: www.tandfonline.com/doi/full/10.1080/07420528.2017.1324878. 127. Cho, Y, et al. (2016), ‘Effects of artificial light at night on human health: A literature review of observational and experimental studies applied to exposure assessment’: www.ncbi.nlm.nih.gov/pubmed/26375320. 128. Codoñer-Franch, P. and Gombert, M. (2018), ‘Circadian rhythms in the pathogenesis of gastrointestinal diseases’, World Journal of Gastroenterology, 24(38): 4297–4303. 129. Tähkämö, L., et al. (2019), ‘Systematic review of light exposure impact on human circadian rhythm’: www.tandfonline.com/doi/full/10.1080/07420528.2018. 1527773. 130. Prayag, A., et al. (2019), ‘Light Modulation of Human Clocks, Wake, and Sleep’: www.mdpi.com/2624-5175/1/1/17. 131. Leese, G., et al. (1996), ‘Short-term night-shift working mimics the pituitary-adrenocortical dysfunction in chronic fatigue syndrome’: https://academic.oup.com/jcem/article-lookup/doi/10.1210/jcem.81.5.8626849. Глава 11. Иммунная система и снижение нагрузки на организм 132. Cressey, D. (2011), ‘XMRV paper withdrawn’: http://blogs.nature.com/news/ 2011/12/xmrv-paper-withdrawn.html. 133. Anand, S.K. and Tikoo, S.K. (2013), ‘Viruses as Modulators of Mitochondrial Functions’, Advances in Virology, vol. 2013, Article ID 738794. 134. Centers for Disease Control and Prevention (2018), ‘Possible Causes | Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)’: www.cdc.gov/me-cfs/ about/possible-causes.html. 135. Ikuta, K., et al. (2003), ‘Diagnostic evaluation of 2′, 5′-oligoadenylate synthetase activities and antibodies against Epstein-Barr virus and Coxiella burnetii in patients with chronic fatigue syndrome in Japan’: www.sciencedirect.com/science/article/abs/pii/S1286457903002193?via%3Dihub. 136. Eriksen, W. (2018), ‘ME/CFS, case definition, and serological response to Epstein-Barr virus. A systematic literature review’: www.tandfonline.com/doi/full/ 10.1080/21641846.2018.1503125. 137. Rasa, S., et al. (2018), ‘Chronic viral infections in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)’: https://www.ncbi.nlm.nih.gov/pmc/articles/ PMC6167797/. 138. Yalcin, S., et al. (1994), ‘Prevalence of Human Herpesvirus 6 Variants A and B in Patients with Chronic Fatigue Syndrome’: http://doi.wiley.com/10.1111/ j.1348–0421.1994.tb01827.x. 139. Eldin, C., et al. (2017), ‘From Q Fever to Coxiella burnetii Infection: a Paradigm Change’: www.ncbi.nlm.nih.gov/pubmed/27856520 2017. 140. Buchwald, D., et al. (1996), ‘Viral serologies in patients with chronic fatigue and chronic fatigue syndrome’: http://doi.wiley.com/10.1002/%28SICI%291096-9071%28199609%2950%3A1%3C25%3A%3AAID-JMV6%3E3.0.CO%3B2-V. 141. Koelle, D.M., et al (2002), ‘Markers of Viral Infection in Monozygotic Twins Discordant for Chronic Fatigue Syndrome’: https://academic.oup.com/cid/article-lookup/doi/10.1086/341774. 142. Brewer, J.H., et al. (2013), ‘Detection of Mycotoxins in Patients with Chronic Fatigue Syndrome’: www.ncbi.nlm.nih.gov/pmc/articles/PMC3705282/. 143. Chester, A.C. and Levine, P.H. (1994), ‘Concurrent Sick Building Syndrome and Chronic Fatigue Syndrome: Epidemic Neuromyasthenia Revisited’: http://academic.oup.com/cid/article/18/Supplement_1/S43/317008/Concurrent-Sick- Building-Syndrome-and-Chronic. 144. Campbell, A.W., et al. (2004), ‘Mold and Mycotoxins: Effects on the Neurological and Immune Systems in Humans’: www.sciencedirect.com/science/article/pii/S0065216404550153?via%3Dihub Adv. 145. Rea, W.J., et al. (2003), ‘Effects of Toxic Exposure to Molds and Mycotoxins in Building-Related Illnesses’: https://pubmed.ncbi.nlm.nih.gov/15143852/. 146. Ratnaseelan, A.M, et al. (2018), ‘Effects of Mycotoxins on Neuropsychiatric Symptoms and Immune Processes’: www.clinicaltherapeutics.com/article/S0149-2918(18)30229-7/fulltext. 147. Centers for Disease Control and Prevention (2019), ‘Lyme and Other Tickborne Diseases Increasing’: www.cdc.gov/media/dpk/diseases-andconditions/lyme-disease/ index.html. Глава 13. Научитесь прислушиваться к своему телу 148. White, P.D., et al. (2011), ‘Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): a randomised trial’: www.ncbi.nlm.nih.gov/pubmed/21334061. 149. Wilshire, C., et al. (2017), ‘Can patients with chronic fatigue syndrome really recover after graded exercise or cognitive behavioural therapy? A critical commentary and preliminary reanalysis of the PACE trial’: www.tandfonline.com/doi/ full/10.1080/21641846.2017.1259724. 150. Wilshire, C.E., et al. (2018), ‘Rethinking the treatment of chronic fatigue syndrome — a reanalysis and evaluation of findings from a recent major trial of graded exercise and CBT’: www.ncbi.nlm.nih.gov/pubmed/29562932BMC. 151. Sharpe, M., et al. (2019), ‘The PACE trial of treatments for chronic fatigue syndrome: a response to Wilshire et al.’: www.ncbi.nlm.nih.gov/pubmed/30871632. 152. Wilshire, C.E. and Kindlon, T. (2019), ‘Response: Sharpe, Goldsmith and Chalder fail to restore confidence in the PACE trial findings’: www.ncbi.nlm.nih.gov/pubmed/30914065. 153. Torjesen, I. (2015), ‘Tackling fears about exercise is important for ME treatment, analysis indicates’: www.bmj.com/cgi/doi/10.1136/bmj.h227. 154. Twisk, F. and Maes, M. (2009), ‘A review on cognitive behavorial therapy (CBT) and graded exercise therapy (GET) in myalgic encephalomyelitis (ME)/chronic fatigue syndrome (CFS): CBT/GET is not only ineffective and not evidencebased, but also potentially harmful for many patients with ME/CFS’: www.researchgate.net/publication/38034776_A_review_on_cognitive_behavorial_ therapy_CBT_and_graded_exercise_therapy_GET_in_myalgic_encephalomyelitis_ ME_chronic_fatigue_syndrome_CFS_CBTGET_is_not_only_ineffective_and_not_evidencebased_but_also. Глава 15. Как привести тело в состояние исцеления 155. Lardone, A. et al. (2018), ‘Mindfulness Meditation Is Related to Long-Lasting Changes in Hippocampal Functional Topology during Resting State: A Magnetoencephalography Study’: www.ncbi.nlm.nih.gov/pmc/articles/ PMC6312586/. 156. Braboszcz, C., et al. (2017), ‘Increased Gamma Brainwave Amplitude Compared to Control in Three Different Meditation Traditions’: www.ncbi.nlm.nih.gov/pmc/ articles/PMC5261734/. 157. Cahn, B.R., et al. (2013), ‘Event-related delta, theta, alpha and gamma correlates to auditory oddball processing during Vipassana meditation’: www.ncbi.nlm.nih.gov/pmc/articles/PMC3541491/. 158. Amihai, I. and Kozhevnikov, M. (2014), ‘Arousal vs. Relaxation: A Comparison of the Neurophysiological and Cognitive Correlates of Vajrayana and Theravada Meditative Practices’: www.ncbi.nlm.nih.gov/pmc/articles/PMC4106862/. 159. Fucci, E., et al. (2018), ‘Differential effects of non-dual and focused attention meditations on the formation of automatic perceptual habits in expert practitioners’: www.ncbi.nlm.nih.gov/pmc/articles/PMC7050275/. Глава 16. Основы питания 160. Guandalini, S. and Newland C. (2011), ‘Differentiating Food Allergies from Food Intolerances’: http://link.springer.com/10.1007/s11894-0110215-7.